OMEROS CORP Operating Leases, Rent Expense
OMEROS CORP (OMER) reported Operating Leases, Rent Expense of $4.50 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2015-03-16
- OMEROS CORP operating leases, rent expense for fiscal 2014 was $4.50M, a 4.65% increase from fiscal 2013.
- OMEROS CORP operating leases, rent expense for fiscal 2013 was $4.30M, a 48.28% increase from fiscal 2012.
- OMEROS CORP operating leases, rent expense for fiscal 2012 was $2.90M, a 31.82% increase from fiscal 2011.
- OMEROS CORP operating leases, rent expense for fiscal 2011 was $2.20M, a 4.76% increase from fiscal 2010.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2014-12-31 | $4.50M 10-K · filed 2015-03-16 |
| 2013-12-31 | $4.30M 10-K · filed 2015-03-16 |
| 2012-12-31 | $2.90M 10-K · filed 2015-03-16 |
| 2011-12-31 | $2.20M 10-K · filed 2014-03-13 |
| 2010-12-31 | $2.10M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |